Ashfield Capital Partners, LLC Bio N Tech Se Transaction History

Ashfield Capital Partners, LLC

  • $1.19 Billion
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022
SELL
$123.25 - $186.24 $1.67 Million - $2.53 Million
-13,587 Closed
0 $0
Q1 2022

May 11, 2022
SELL
$126.25 - $231.85 $75,118 - $137,950
-595 Reduced 4.2%
13,587 $2.32 Million
Q4 2021

Feb 02, 2022
BUY
$216.64 - $362.52 $35,095 - $58,728
162 Added 1.16%
14,182 $3.66 Million
Q3 2021

Nov 09, 2021
BUY
$205.93 - $447.23 $2.89 Million - $6.27 Million
14,020 New
14,020 $3.83 Million

Others Institutions Holding BNTX

# of Institutions
358
Shares Held
38.4M
Call Options Held
2.45M
Put Options Held
2.29M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $24.2B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Ashfield Capital Partners, LLC Portfolio

Follow Ashfield Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashfield Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashfield Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email